FOLD - Abeona Therapeutics: A Potential Leader In Gene Therapy
Company overview
Abeona Therapeutics (ABEO) is a clinical stage biopharmaceutical company focused on gene and cell therapy for rare genetic disease. This company has a long history starting from Access Pharmaceuticals established in 1974. It evolved with several mergers and acquisitions in the past 40 years and changed name a few times in the history. Back in 2015, the company (the name was changed to PlasmaTech Biopharmaceuticals at that time) acquired a small biotech company, Abeona Therapeutics LLC, and then changed the name from PlasmaTech to Abeona Therapeutics shortly afterwards. This acquisition helped the company